The Emmes Corporation today announced its participation in a three-year study testing the results of two different opioid treatment medications. The research, published in one of the world’s oldest and best known medical journals, concluded that for those able to begin treatment, both drugs are nearly equal in their safety and effectiveness. The National Institute on Drug Abuse (NIDA) funded the research.
{iframe}https://www.morningstar.com/news/pr-news-wire/PRNews_20171220DC73655/seven-emmes-employees-recognized-in-lancet-study-comparing-two-opioid-treatments.print.html{/iframe}